Long-term Follow-Up and Factors Predictive of Recurrence in Barrett's Esophagus Treated by Argon Plasma Coagulation and Acid Suppression

Michel Kahaleh, Jean‐Luc Van Laethem, Noémi Nagy, +2

Endoscopy

OncologyEsophagusEsophageal CancerEsophagus TreatedGastroenterology +6

Expression of Certain Leukemia/Lymphoma Related microRNAs and its Correlation with Prognosis in Childhood Acute Lymphoblastic Leukemia

Karolina Nemes, Monika Csóka, Noémi Nagy, +6

Pathology & Oncology Research

Hematological MalignancyTumor BiologyMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder +7

Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib

Ambrus Gángó, Donát Alpár, Bence Gálik, +18

International Journal of Cancer

Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease – a combined tissue microarray, in vitro and in vivo study

Ágnes Márk, Melinda Hajdú, Zsófia Váradi, +8

BMC Cancer

Activity and complexes of mTOR in diffuse large B-cell lymphomas—a tissue microarray study

Anna Sebestyén, T. Sticz, Ágnes Márk, +6

Modern Pathology

Hematological MalignancyTumor BiologyLymphoid NeoplasiaImmunologyCancer Cell Biology +4

Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms

Ambrus Gángó, Réka Mózes, Zsófia Boha, +24

Leukemia Research

Hematological MalignancyTumor BiologyOncologyMedicineHematology +9

Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells

Zoltán Hujber, Gábor Petővári, Norbert Szoboszlai, +9

Journal of Experimental & Clinical Cancer Research

mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression

T. Sticz, Anna Molnár, Ágnes Márk, +6

Journal of Clinical Pathology

Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma

Ákos Nagy, Bence Bátai, Alexandra Balogh, +10

Genes

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

Gábor Petővári, Zoltán Hujber, Ildikó Krencz, +10

Cancer Cell International